261 related articles for article (PubMed ID: 23415907)
1. Reduced hepatotoxicity by total glucosides of paeony in combination treatment with leflunomide and methotrexate for patients with active rheumatoid arthritis.
Chen Z; Li XP; Li ZJ; Xu L; Li XM
Int Immunopharmacol; 2013 Mar; 15(3):474-7. PubMed ID: 23415907
[TBL] [Abstract][Full Text] [Related]
2. Total glucosides of paeony can reduce the hepatotoxicity caused by Methotrexate and Leflunomide combination treatment of active rheumatoid arthritis.
Xiang N; Li XM; Zhang MJ; Zhao DB; Zhu P; Zuo XX; Yang M; Su Y; Li ZG; Chen Z; Li XP
Int Immunopharmacol; 2015 Sep; 28(1):802-7. PubMed ID: 26292180
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of total glucosides of paeony combined with methotrexate and leflunomide for active rheumatoid arthritis: a meta-analysis.
Huang Y; Wang H; Chen Z; Wang Y; Qin K; Huang Y; Ba X; Lin W; Tu S
Drug Des Devel Ther; 2019; 13():1969-1984. PubMed ID: 31354242
[No Abstract] [Full Text] [Related]
4. Clinical safety of total glucosides of paeony adjuvant therapy for rheumatoid arthritis treatment: a systematic review and meta-analysis.
Liu B; Meng X; Ma Y; Li H; Liu Y; Shi N; Chen Y; Wang Y; Lu C
BMC Complement Med Ther; 2021 Mar; 21(1):102. PubMed ID: 33771151
[TBL] [Abstract][Full Text] [Related]
5. Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate. Utilization of Leflunomide in the Treatment of Rheumatoid Arthritis Trial Investigator Group.
Cohen S; Cannon GW; Schiff M; Weaver A; Fox R; Olsen N; Furst D; Sharp J; Moreland L; Caldwell J; Kaine J; Strand V
Arthritis Rheum; 2001 Sep; 44(9):1984-92. PubMed ID: 11592358
[TBL] [Abstract][Full Text] [Related]
6. Elevated liver enzyme tests among patients with rheumatoid arthritis or psoriatic arthritis treated with methotrexate and/or leflunomide.
Curtis JR; Beukelman T; Onofrei A; Cassell S; Greenberg JD; Kavanaugh A; Reed G; Strand V; Kremer JM
Ann Rheum Dis; 2010 Jan; 69(1):43-7. PubMed ID: 19147616
[TBL] [Abstract][Full Text] [Related]
7. [Comparative study on clinical efficacy of using methotrexate singly or combined with total glucosides of Paeony in treating rheumatoid arthritis].
Du JH; Dong BD
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2005 Jun; 25(6):540-2. PubMed ID: 16025972
[TBL] [Abstract][Full Text] [Related]
8. Liver toxicity is rare in rheumatoid arthritis patients using combination therapy with leflunomide and methotrexate.
Alves JA; Fialho SC; Morato EF; Castro GR; Zimmermann AF; Ribeiro GG; Neves FS; Pereira IA
Rev Bras Reumatol; 2011; 51(2):141-4. PubMed ID: 21584420
[TBL] [Abstract][Full Text] [Related]
9. [Clinical observation on effect of total glucosides of paeony combined with methotrexate on rheumatoid arthritis].
Wang Y; Xing HY
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2007 Sep; 27(9):839-40. PubMed ID: 17969901
[TBL] [Abstract][Full Text] [Related]
10. Comparative effectiveness of rituximab in combination with either methotrexate or leflunomide in the treatment of rheumatoid arthritis.
Narváez J; Díaz-Torné C; Ruiz JM; Hernández MV; Torrente-Segarra V; Ros S; Rodriguez de la Serna A; Díaz-López C; Sanmartí R; Nolla JM
Semin Arthritis Rheum; 2011 Dec; 41(3):401-5. PubMed ID: 21862107
[TBL] [Abstract][Full Text] [Related]
11. Combination leflunomide and methotrexate (MTX) therapy for patients with active rheumatoid arthritis failing MTX monotherapy: open-label extension of a randomized, double-blind, placebo controlled trial.
Kremer J; Genovese M; Cannon GW; Caldwell J; Cush J; Furst DE; Luggen M; Keystone E; Bathon J; Kavanaugh A; Ruderman E; Coleman P; Curtis D; Kopp E; Kantor S; Weisman M; Waltuck J; Lindsley HB; Markenson J; Crawford B; Fernando I; Simpson K; Strand V
J Rheumatol; 2004 Aug; 31(8):1521-31. PubMed ID: 15290730
[TBL] [Abstract][Full Text] [Related]
12. Effects of total glucosides from paeony (Paeonia lactiflora Pall) roots on experimental atherosclerosis in rats.
Li J; Chen CX; Shen YH
J Ethnopharmacol; 2011 May; 135(2):469-75. PubMed ID: 21453765
[TBL] [Abstract][Full Text] [Related]
13. Dose escalation of parenteral methotrexate in active rheumatoid arthritis that has been unresponsive to conventional doses of methotrexate: a randomized, controlled trial.
Lambert CM; Sandhu S; Lochhead A; Hurst NP; McRorie E; Dhillon V
Arthritis Rheum; 2004 Feb; 50(2):364-71. PubMed ID: 14872477
[TBL] [Abstract][Full Text] [Related]
14. A systemic review and meta-analysis of the clinical efficacy and safety of total glucosides of peony combined with methotrexate in rheumatoid arthritis.
Feng ZT; Xu J; He GC; Cai SJ; Li J; Mei ZG
Clin Rheumatol; 2018 Jan; 37(1):35-42. PubMed ID: 28748514
[TBL] [Abstract][Full Text] [Related]
15. [Clinical observation on effects of leflunomid and total glucosides of paeony on rheumatoid arthritis].
Zhao YX; Liu Y
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2006 Apr; 26(4):355-7. PubMed ID: 16689008
[TBL] [Abstract][Full Text] [Related]
16. The SMILE study -- safety of methotrexate in combination with leflunomide in rheumatoid arthritis.
Bird P; Griffiths H; Tymms K; Nicholls D; Roberts L; Arnold M; Burnet S; de Jager J; Scott J; Zochling J; Littlejohn G
J Rheumatol; 2013 Mar; 40(3):228-35. PubMed ID: 23322457
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics, safety, and efficacy of combination treatment with methotrexate and leflunomide in patients with active rheumatoid arthritis.
Weinblatt ME; Kremer JM; Coblyn JS; Maier AL; Helfgott SM; Morrell M; Byrne VM; Kaymakcian MV; Strand V
Arthritis Rheum; 1999 Jul; 42(7):1322-8. PubMed ID: 10403258
[TBL] [Abstract][Full Text] [Related]
18. Leflunomide, a new disease-modifying drug for treating active rheumatoid arthritis in methotrexate-controlled phase II clinical trial.
Bao C; Chen S; Gu Y; Lao Z; Ni L; Yu Q; Xu J; Li X; Liu J; Sun L; He P; Ma J; Xu S; Ding C
Chin Med J (Engl); 2003 Aug; 116(8):1228-34. PubMed ID: 12935395
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of leflunomide or methotrexate plus subcutaneous tumour necrosis factor-alpha blocking agents in rheumatoid arthritis.
Benucci M; Saviola G; Baiardi P; Manfredi M; Sarzi-Puttini P; Atzeni F
Int J Immunopathol Pharmacol; 2011; 24(1):269-74. PubMed ID: 21496415
[TBL] [Abstract][Full Text] [Related]
20. Reduction of the efficacy of methotrexate by the use of folic acid: post hoc analysis from two randomized controlled studies.
Khanna D; Park GS; Paulus HE; Simpson KM; Elashoff D; Cohen SB; Emery P; Dorrier C; Furst DE
Arthritis Rheum; 2005 Oct; 52(10):3030-8. PubMed ID: 16200612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
